146 related articles for article (PubMed ID: 11684931)
1. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery.
Hoffmann C; Tabrizian S; Wolf E; Eggers C; Stoehr A; Plettenberg A; Buhk T; Stellbrink HJ; Horst HA; Jäger H; Rosenkranz T
AIDS; 2001 Nov; 15(16):2119-27. PubMed ID: 11684931
[TBL] [Abstract][Full Text] [Related]
2. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.
Skiest DJ; Crosby C
AIDS; 2003 Aug; 17(12):1787-93. PubMed ID: 12891064
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment.
Aboulafia DM; Puswella AL
AIDS Patient Care STDS; 2007 Dec; 21(12):900-7. PubMed ID: 18154487
[TBL] [Abstract][Full Text] [Related]
4. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
[TBL] [Abstract][Full Text] [Related]
5. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma.
Diamond C; Taylor TH; Im T; Miradi M; Wallace M; Anton-Culver H
Curr HIV Res; 2006 Jul; 4(3):375-8. PubMed ID: 16842088
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
[TBL] [Abstract][Full Text] [Related]
8. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
Hoffmann C; Wolf E; Fätkenheuer G; Buhk T; Stoehr A; Plettenberg A; Stellbrink HJ; Jaeger H; Siebert U; Horst HA
AIDS; 2003 Jul; 17(10):1521-9. PubMed ID: 12824790
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.
Lascaux AS; Hemery F; Goujard C; Lesprit P; Delfraissy JF; Sobel A; Lepage E; Lévy Y
AIDS Res Hum Retroviruses; 2005 Mar; 21(3):214-20. PubMed ID: 15795527
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study.
Hentrich M; Maretta L; Chow KU; Bogner JR; Schürmann D; Neuhoff P; Jäger H; Reichelt D; Vogel M; Ruhnke M; Oette M; Weiss R; Rockstroh J; Arasteh K; Mitrou P
Ann Oncol; 2006 Jun; 17(6):914-9. PubMed ID: 16565210
[TBL] [Abstract][Full Text] [Related]
11. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
González-Aguilar A; Soto-Hernández JL
Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
[TBL] [Abstract][Full Text] [Related]
12. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
Uldrick TS; Pipkin S; Scheer S; Hessol NA
AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in AIDS-related primary central nervous system lymphoma.
Gupta NK; Nolan A; Omuro A; Reid EG; Wang CC; Mannis G; Jaglal M; Chavez JC; Rubinstein PG; Griffin A; Abrams DI; Hwang J; Kaplan LD; Luce JA; Volberding P; Treseler PA; Rubenstein JL
Neuro Oncol; 2017 Jan; 19(1):99-108. PubMed ID: 27576871
[TBL] [Abstract][Full Text] [Related]
15. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
Antinori A; Cingolani A; Alba L; Ammassari A; Serraino D; Ciancio BC; Palmieri F; De Luca A; Larocca LM; Ruco L; Ippolito G; Cauda R
AIDS; 2001 Aug; 15(12):1483-91. PubMed ID: 11504980
[TBL] [Abstract][Full Text] [Related]
16. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.
Berenguer J; Miralles P; Ribera JM; Rubio R; Valencia E; Mahillo B; Pintado V; Palacios R; Montes ML; Téllez MJ; La Cruz J; Torre-Cisneros J; Rodríguez-Arrondo F; Sepúlveda MA; Gutiérrez F; Peralta G; Boix V
J Acquir Immune Defic Syndr; 2008 Apr; 47(4):422-8. PubMed ID: 18434957
[TBL] [Abstract][Full Text] [Related]
18. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.
Tam HK; Zhang ZF; Jacobson LP; Margolick JB; Chmiel JS; Rinaldo C; Detels R
Int J Cancer; 2002 Apr; 98(6):916-22. PubMed ID: 11948473
[TBL] [Abstract][Full Text] [Related]
19. Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy.
Gérard L; Galicier L; Boulanger E; Quint L; Lebrette MG; Mortier E; Meignin V; Oksenhendler E
AIDS; 2003 Jan; 17(1):81-7. PubMed ID: 12478072
[TBL] [Abstract][Full Text] [Related]
20. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.
Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Flores A; Millá F; Feliu E
Br J Haematol; 2001 Mar; 112(4):909-15. PubMed ID: 11298585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
